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Renal tubule regeneration after ischemic injury is coupled to the
up-regulation and activation of cyclins and cyclin dependent kinases.
Proliferation of renal tubules after acute injury is a reactive process of
renal regeneration for recovery of renal function. Molecular and cellular
mechanisms of the re-entrance of renal cells into the cell cycle after injury
remain largely unknown. We have measured the correlations among the
extent of proliferative activity and expression of cyclins and CDKs, and
activity of each CDK during the regeneration period in the outer medullae
of kidneys after ischemic injury in rats. The ratio of proliferating cell
nuclear antigen (PCNA) positively immuno-stained nuclei to total nuclei
per each section of the outer medulla of kidney indicated the proliferative
index (P1) for this study. P1 in the control period was 0.1%. The P1 was
increased at day 1(13.4%), remained at a plateau at days 3 and 5 (30.5 and
32.3%), and decreased at day 7 and day 14 (17.3 and 12.2%) after ischemic
injury. Proliferative activity was readily detectable in renal tubules, but was
hardly detectable in glomeruli or blood vessels. As the PT increased, the
mRNA and protein levels of cyclins Dl, D3 and B, the mRNA levels of
cyclin A, the protein levels of CDK4 and CDK2, and the activities of
CDKs (CDK4, CDK2 and cdc2) increased in the outer medullae of
kidneys after ischemic injury. These findings suggest that the temporal
induction of proliferative activity in Outer medullaiy tubules was closely
linked with the cyclin/CDK system for regeneration of kidney after
ischemic injury.
The kidney has a remarkable capacity for restoring its structure
and function after ischemic or toxic acute renal failure [1—3].
Experimental data suggest that the recovery of renal function
after ischemic or nephrotoxic acute renal failure (ARF) is due to
a replicative repair process of renal tubule cells [1—3], which
predominantly depends on paracrine or autocrine release of
growth factors [4]. These growth factors promote renal tubule cell
proliferation and a differentiation phase dependent on the inter-
action between tubule cells and basement membrane. The iden-
tification of molecular mechanisms by which renal repair occurs
after acute renal failure may lead to potential therapeutic modal-
ities that accelerate renal repair to lessen the morbidity and
mortality.
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A number of cell-cycle regulatory proteins have been identified
and categorized as either cyclins, cyclin dependent kinases
(CDKs) or cyclin dependent kinase inhibitors (CDKI5) [5—9].
Cyclins are a family of proteins whose production oscillates during
the cell cycle. Based on sequence similarities, they are subdivided
into the classes A, B, D, E, F and G [5—9]. Cyclins are also
classified as Gi and S phase cyclins, or G2 and mitotic (M) phase
cyclins, depending on the role and the protein abundance during
the cell cycle. Each cyclin requires an association with its specific
CDK to regulate the progression of the cell cycle [5—11]. Several
CDKs, including cdc2, CDK2, CDK4 and CDK6 have been
characterized with respect to their temporal activation and their
cyclin partners [10, 11]. D-type cyclins are increased by growth
factor stimulation, and associate with CDK4 and CDK6, whereas
cyclin E associates with CDK2. Both types of cyclins allow the cell
to proceed through the GuS phase transition. Cyclin A associates
with CDK2 or cdc2 and regulates the transition through the S and
G2 phases. 2yclin B binds to cdc2 and controls entry into the
mitotic phase. Cyclin/CDK function is regulated by cyclin avail-
ability and phosphorylation state of specific serine or threonine
residues of CDKs [10, 11].
Recently, we reported that expression of cyclins and CDKs
were high in fetal kidney and decreased after birth [121. In
particular, the expression of cyclin A and B were positively and
closely related to the renal cell cycle during renal development,
and these cyclins disappeared rapidly after birth. However, ex-
pression of cyclins did not change during compensatory renal
hypertrophy or in the reduced renal mass model in adult rat
kidneys [12]. Renal tubule cells have an active regenerative and
proliferative ability upon ARF [1—3]. To determine how this
regenerative and proliferative ability is linked to cyclin/CDK
system, we examined the temporal correlations among the extent
of proliferative activity and expression of cyclins and CDKs, and
activity of each CDK during the regeneration period in outer
medulla of kidney after ischemic injury in the rat. Based on PCNA
immunohistological data, the outer medullary portion of the
kidney was chosen because, first, the renal cortex consisted of
glomeruli that did not show proliferative activity after ischemic
renal injury and tubules that did show heterogeneous (uneven)
proliferative activity (in fact, preliminary experiments in total
kidney and cortical portions of kidney after ischemic injury were
equivocal), and second, the outer medullaiy portion of the kidney
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consisted of tubules (including S3 segment tubules of proximal
tubules) that proliferated actively in a homogeneous manner.
METHODS
Experimental animals and sampling
Animal experiments were conducted according to the "Recom-
mendation from the Declaration of Helsinki and the Guiding
Principles in the Care and Use of Animals." Male and pregnant
female Sprague-Dawley rats were obtained from our breeding
colony. Male rats weighing 200 to 250 g were used for ischemic
renal injury [131, the abdominal cavity was opened via a midline
incision under pentobarbital sodium (30 mg/kg of body wt, i.p.)
anesthesia. Both renal pedicles were exposed and cleaned by blunt
dissection. Microvascular clamps were placed on both renal
arteries and veins to completely block renal blood flow. Core body
temperature was maintained 37°C by placing the animal on a
homeothermic table and was monitored with a temperature-
sensing rectal probe. After 45 minutes, the clamps were removed
and blood flow returned to the kidneys. If reperfusion was
incomplete, as judged visually, the experiment was terminated and
the animal was sacrificed. The sham animals underwent the same
anesthesia and midline abdominal incision, had both renal arter-
ies and veins cleaned and then exposed for 45 minutes, and the
incision was closed. Immediately (control period), and 1, 3, 5, 7, 10
and 14 days after the operation, rats were anesthetized with
pentobarbital sodium, blood was obtained by cardiac puncture for
measuring the concentration of creatinine in serum, kidneys were
harvested, weighed, renal medullae were separated, and stored in
liquid nitrogen. To sample the outer medullary tissue, dissection
was performed from the cortical border of outer medulla to the
cortical border of inner medulla using a razor blade in kidneys
where the cortex had been removed. Kidneys from three animals
in each of the seven groups were analyzed for immunohistochem-
istry. To obtain fetal kidneys as a positive control for measuring
cyclins and CDKs [12], onset of pregnancy in female rats was
determined by vaginal plug. Pregnant rats were killed at gestation
day 19 by decapitation and embryos were removed, decapitated,
kidneys were harvested and were stored in liquid nitrogen.
Assessment of acute renal failure
Assessment of acute renal failure was determined by measuring
the concentration of creatinine in serum at each experimental
time point. Serum concentration of creatinine was measured with
an Autoanalyzer (Hitachi 747, Japan). The serum creatinine levels
(mg/liter) were less than 1.0 at the control period, 2.0 to 4.0 at day
1, 1.5 to 2.5 at day 3, 1.0 to 2.0 at dayS, 0.5 to 1.2 at day 7, and 0.5
to 1.0 at day 14. Animals that had concentrations of serum
creatinine outside of the previously stated were excluded from the
study.
Immunohistology for PCNA and counting of PCNA positive
cells in outer medulla of kidney
For paraffin sections, blood was removed from kidneys using
systemic retrograde perfusion via abdominal aorta with hepa-
rinized physiologic saline and kidneys were fixed in 10% (vol/vol)
neutral buffered formalin, dehydrated through graded alcohols,
and infiltrated with paraffin under standard procedures. Tissue
blocks were sectioned at 4 jim. Deparafflnzied sections were
hydrated, permeahilized in 0.1% (vol/vol) Triton X-100, and
blocked with phosphate buffered saline containing 10% (vol/vol)
goat serum. Sections were incubated with anti-PCNA antibody
(PC-b) at 4°C overnight, and signals were developed with an
avidin-biotin-peroxidase system (Vecstatin ABC kit; Vector Lab.
Inc., Burlingame, CA, USA) with diaminobenzidine (0.01%) as a
chromogen for PCNA. Sections were then counterstained with
Meyer's hematoxylin. PCNA, a DNA polymerase s-associated
protein, was used as a marker for cell proliferation [14]. Positive
PCNA immuno-staining in the nucleus reflects late Gb and early
S phases of the cell cycle [15]. The ratio of PCNA positively
immuno-stained nuclei to total nuclei per each section of the
outer medulla was a reliable proliferative index (P1) for examining
proliferative activity in the kidney. The number of outer medul-
lary tubule nuclei counted per group (each group consisted of 6
kidneys from 3 animals) was between 2,600 to 3,400.
RNA isolation and Northern blot analyses
Total RNA from outer medullary tissues was extracted using
TRI reagent (MRC, Cincinnati, OH, USA) according to the
manufacturer's protocol. RNA samples were quantitated by spec-
trophotometry at 260 nm. For Northern analysis, RNA (20 g)
was denatured with glyoxal, separated by size on 1.2% (wt/vol)
agarose gels, and transferred to GeneScreen (NEN Research
Product, Boston, MA, USA). Probes were radiolabeled by ran-
dom priming method according to the manufacturer's instructions
(Prime-a-Gene; Promega, Madison, WI, USA). Generation of
cDNA probes for cyclin A, B, Dl and D3 using reverse tran-
scriptase-polymerase chain reaction was described in a previous
report [121. Specific activities of probes were typically 2 to 3 x 10°
dpm/g. Hybridizations were for 20 hours at 65°C in 4 >< SSC, 2 X
Denhardt's solution, 0.1% (wt/vol) SDS, and 10 g/ml salmon
sperm DNA. Blots were washed at 65°C in 2 X SSC, 0.1% (wt/vol)
SDS, and signals were visualized by autoradiography at —70°C for
5 to 10 days with an intensifying screen. In all experiments,
integrity, equivalent loading, and complete transfer of the RNA
samples were established by UV shadowing of the blot prior to
hybridization and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) hybridization. All autoradiographic data were quanti-
fied using densitometry (Prism; Improve Vision, Covetiy, UK),
and signals were normalized by corresponding GAPDH signal.
Northern blot analysis was performed at least two times on each
RNA sample.
Western blot
Blood was removed from the outer medulla on filter paper.
Outer medullae were frozen with liquid nitrogen and stored at
—70°C. Samples were homogenized directly in Nonidet P-40
buffer [150 m NaCl, 5 mst EDTA, 50 mi Tris-HCI (pH 8.0), 1
jig/mi aprotinin, I jig/mi pepstatin, 1 jig/mi leupeptin, 50 jig/mI
1-chloro-3-tosylamido-7-amino-2-heptanone, 50 jig/mi phenyl-
methylsuifonyl fluoride, 100 jig/mi L-1-tosylamide-2-phcnyiethyi
chioromethyl ketone, 20 m sodium fluoride, 20 mvt glycerophos-
phate, 1% (vol/vol) Nonidet P-40]. Lysate protein was quantitated
using a Bradford assay (Bio-Rad, Hercules, CA, USA) with
bovine serum albumin as a reference standard. Samples were
boiled with 2 x sample buffer for 10 minutes, separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
system, and electrotransferred to nitroceliulose membranes. The
nitrocellulose membranes were stained with 0.1% (wt/vol) naph-
thol blue black (Amido black) in 10% (vol/vol) acetic acid, and
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40% (vol/vol) methanol to assess the efficiency of transfer. Non-
specific binding was blocked by incubation in blocking buffer [5%
(wt/vol)1 non-fat dry milk, 3% (wtlvol) bovine serum albumin,
0.1% (vol/vol) Tween 20, 1 X PBSI for one hour, and then blots
were incubated with primary antibody for one to two hours at
room temperature. Anti-cyclin Dl monoclonal antibody (72 to
13G), anti-cyclin D3 polyclonal antibody (C-16), anti-cdc2 poly-
clonal antibody (pSTAIE), anti-CDK2 polyclonal antibody (M2),
anti-CDK4 polyclonal antibody (C22), and anti-PCNA monoclo-
nal antibody (PC1O) were used for each blot. All of the antibodies
above were purchased from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA, USA). Anti-cyclin A and anti-cyclin B mono-
clonal antibodies were generously provided by Dr. Michael Bran-
deis (ICRF Clare Hall Lab., Cell cycle Control, UK). Signals
were visualized by the ECL detection method according to the
manufacturer's protocol (Amersham mt. plc, Buckinghamshire,
UK), and quantified using densitometry.
Immunoprecipitation and assay of each CDK activity
Protein lysates (500 sag) were diluted with 1 ml (final volume) of
RIPA-buffer [1% (vol/vol)I Triton X-100, 1% (wt/vol) sodium
deoxycholate, 0.1% (wt/vol) SDS, 0.15 M NaCI and 0.01 M Tris, pH
7.4J, precleaned with 50 i1 of protein A-Sepharose CL-4B beads
(0.15 g/ml; Pharmacia Biotech, Uppsala, Sweden) for one hour at
4°C. The beads were then removed by centrifugation. Precleaned
lysates were then reacted with 2 g of each of antibody (anti-
cyclin Dl antibody for CDK4; anti-cyclin A antibody for CDK2) in
a final 1 ml of RIPA-buffer. The mixture was incubated and
rocked for two hours at 4°C. Fifty microliters of protein A-
Sepharose CL-4B beads were added and the incubation was
continued for an additional hour. Immunocomplexes were col-
lected by centrifugation (3,000 g, 3 mm, 4°C), and washed three
times with ice-cold RIPA-buffer. Half of the immunocomplexes
bound heads was eluted in sample buffer, separated by SDS-
PAGE, and Western blot analysis was performed as described in
above. Purified CDK4 or CDK2 kinase activity in immunoprecipi-
tates was measured using a modification of the methods previ-
ously described [16, 171. Glutathione-S-transferase retinoblas-
toma (GST-Rb) fusion protein (a gift from Dr. Manjun Ha, Ajou
Univ., Korea) or histone HI was used for determining the
activities of CDK4 or CDK2 as the substrate. The remaining half
of immunocomplex bound heads was suspended in kinase buffer
(10 WM MgCI7, 5 msi MnCl7, 1 mvi DTT, 50 mivi HEPES-NaOH,
pH 7.3), and washed twice in kinase buffer. Reactions were
carried out in kinase buffer (final volume, 50 id) with 0.1 tg of
GST-Rb or 2.5 g of histone HI (Calbiochem, La Jolla, CA,
USA), 0.1 mt ATP and 5.0 /.LCi [y-32PIATP at 30°C for 20
minutes, and stopped by adding 2 X SDS sample buffer. The
optimum incubation time was determined by measuring several
time points of histone HI phosphorylation (data not shown). Final
reactants were separated using SDS-PAGE, fixed with S to 10
volumes of glacial acetic acid:methanol:water (10:20:70), dried,
and autoradiographed, and signals were quantified using densi-
tometry. Activity of cdc2 was measured using Marshak's method
[181. The reactions for cdc2 activity were carried out in an assay
mixture containing cdc2 buffer (50 mrvi Tris-HCI, pH 8.0; 10 mM
Mg Cl7; 1 mrvi dithiothreitol; 1 mrvi EGTA), 5 id ATP {[y-32P1
ATP, 0.6 mi, 500 to 1,000 cpm/pmol}, 5 d substrate peptide
(CSH1O3:H-A-D-A-Q-H-A-T-P-P-K-K-K-R-K-V-E-D-P-K-D-F-
OH, stock solution, 6 m in buffer) and 5 jtg of sample protein, in
a total volume 30 jd. The mixture was incubated at 30°C for 10
minutes, and the reaction was stopped by the addition of trichlo-
roacetic acid to a final concentration of 10% (wt/vol). Following
centrifugation to remove precipitated protein, aliquots (10 pA) of
the supernatants were applied to a strip of phosphocellulose
paper (Whatman P81) to immobilize the peptide. The paper was
washed four times for five minutes each time in 2 L of 100 mvi
phosphoric acid, dried, and the radioactivity was measured by
scintillation counter (Tri-Carb 2300 TR; Packard, Downers
Grove, IL, USA).
RESULTS
Estimation of proliferative activity using immunohistology of
PCNA
Immunohistology of PCNA was employed to monitor temporal
and spatial level of proliferative activity in kidneys after ischemic
injury. Detection of PCNA protein in tissue sections was clear and
obvious, and appeared as intense dark-brown stained, and was
readily observed in nuclei among a background of lighter hema-
toxylin-stained nuclei (Fig. 1). Control slides, that used either
nonimmune rabbit serum (for polyclonal antibody) or irrelevant
monoclonal antibodies, did not have any immunoreactivity (data
not shown). Variable immuno-staining patterns were visualized at
different time periods and different locations of kidneys after
ischemic injury. The positive PCNA immuno-staining was readily
detectable in renal tubules, interstitial cells and transitional
epithelium of papilla, hut was hardly detectable in glomeruli and
blood vessels. Figure 1 shows the pattern of PCNA immuno-
staining in renal cortex and outer medulla at day 5 after ischemic
injury (A and C) and sham-operated rat (B and D). While the
renal cortex revealed heterogeneous pattern of PCNA immuno-
staining, that is, negative in glomerulus and heterogeneous (un-
even) positive in tubules around glomerulus (Fig. IA); the outer
medulla of kidney, which includes S3 segment tubules of proximal
tubules, showed a homogeneous (even) pattern of positive PCNA
immuno-staining (Fig. IC). Positive PCNA immuno-staining was
hardly detectable in renal cortex (Fig. 1B) and outer medulla (Fig.
ID) of sham-operated rats, Positive thymidine incorporation in
kindeys were co-localized with positive PCNA staining (data not
shown). In the control period, P1 (defined in the Methods section)
in the outer medullary tubule was 0.1%. After ischemic injury, P1
of outer medullary renal tubules was increased at day 1 (13.4%),
remained at a plateau at days 3 and 5 (30.5% and 32.3%), and
decreased at days 7 and 14 (17.3% and 12.2%). Results from
quantification of PCNA in outer medulla during regeneration by
Western blot analysis (Figs. 6 and 7) and immunohistochemical
analysis were similar. The PCNA induction occurred in a day,
remained at a plateau at three and five days, and decreased
gradually thereafter. The plateau level of PCNA at days 3 and 5
was 40.4% and 38.5% of the PCNA level in kidneys of gestation
day 15, which had a high proliferative activity.
Temporal expression of cyclins, CDKs and PCNA during tubule
regeneration in outer medullae of kidneys
Northern and Western blot analyses were employed to monitor
temporal expression of cell cyclins and CDKs during tubule
regeneration in outer medullae of adult animals (Figs. 2, 3 and 4).
The mRNA levels of the Dl and D3 were highly detectable in
fetal kidney, while they were barely detectable in outer medullae
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Fig. 1. Light micrographs of cortical (A and B) and outer strip of outer medullary (C and D) portions of kidneys that were immuno-stained with PCNA
antibody five days after ischemic injury (A and C) and after sham operation (B and D). (A) Immuno-positive staining (arrow) nuclei in cells of tubules
around glomerulus was heterogeneous, whereas no immuno-positive stained nuclei in cells of glomerulus (magnification X400). (B) No immuno-positive
staining nuclei in cells of both tubules and glomeruli (x400). (C) The population of PCNA immuno-positive nuclei staining cells were abundant and
homogeneous relatively in the S3 segment of proximal tubules in outer medullae (X400). (D) Almost no PCNA immuno-positive nuclei staining cells
in S3 segment of proximal tubules in outer medullae (X400). Reproduction of this figure in color was supported by a grant from Choongwae
Pharmaceutical Company, Chonju, Korea.
of adult animals at the control period (Fig. 2). Their levels
increased gradually by day 5, and recovered to basal levels by day
14. As our previous study showed [12], two cyclin Dl protein
bands were detectable in fetal kidneys (Fig. 3A). The upper band
indicated phosphorylatcd active cyclin Dl, whereas the lower
band indicated unphosphoxylated inactive cyclin Dl. The phos-
phorylated form of cyclin Dl was not detectable in the outer
medullae of adult kidneys at the control period. Phosphorylated
cyclin Dl appeared at day 1, peaked at day 3, maintained a
constant level at day 7, and both forms of cyclin Dl levels were
decreased by day 14. (Fig. 3), The protein level of two forms of
cyclin Dl at day 3 after injury was comparable with the level in
fetal kidneys. Cyclin D3 protein was highly detectable in fetal
kidneys, while it was not detectable in the outer medullae of adult
kidneys at the control period (Fig. 3). However, the cyclin D3
reappeared at day 1, increased by day 7, then decreased gradually
to basal level by day 14 (Fig. 3). As a time control, there were no
noticeable changes of mRNA or protein levels of cyclin Dl or
cyclin D3 in the outer medullae of kidneys at any time point of
sham-operated rats (data not shown).
Two sizes of cyclin A transcripts (4.8 kh and 2.4 kh) were
detectable in fetal kidneys, but they were not detectable in the
outer medullae of adult kidneys at the control period (Fig. 2). Both
cyclin A transcripts were detectable at day I, were increased by
day 3, then were decreased gradually by day 14. However, cyclin A
protein was not readily detectable during the regeneration period,
while cyclin A protein was highly detectable in fetal kidneys (Fig.
3). The possible reasons that cyclin A protein was not readily
detectable during the regeneration period may he that (1) the
sensitivity of Western blot analysis may be too low to detect subtle
increases of cyclin A protein or (2) rapid degradation of cyclin A.
Patterns of cyclin B mRNA and protein expression were different
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from those of cyclin A. Two sizes of cyclin B transcripts (2.4 Kb
and 1.6 Kb) were expressed in fetal kidneys, while they were not
detectable in the outer medullae of adult kidneys at the control
period. Both cyclin B transcripts reappeared at day 3, then
gradually decreased and disappeared by day 14. Cyclin B protein
was readily detectable in fetal kidneys, while it was not detectable
at the control period (Fig. 3). Cyclin B protein was noticeably
detectable at day 1, gradually increased, and remained detectable
by day 14. There were no changes of mRNA or protein levels of
cyclin A or cyclin B in outer medullae at any time point of
sham-operated rats (data not shown).
The protein levels of CDK4, CDK2, cdc2, and PCNA were high
in fetal kidney, while they were comparatively low in the outer
medullae of adult kidneys at the control period (Fig. 4). The
protein levels of CDK4 and CDK2 were not changed at day 1,
however, while the levels of CDK4 increased at days 5 and 7, and
decreased at day 10, and the levels of CDK2 increased at day 3,
reached a plateau at days 5 and 7, and decreased at day 10 (Fig.
4). The protein level of cdc2 only increased slightly at days 3 and
5. PCNA had markedly increased in outer medullae of kidneys at
day 1, was even greater by day 5, and then was decreased by day
14 although levels were still higher than control period levels.
There were rio noticeable changes of protein levels of CDK4,
0
F Cl
Fig. 2. A. Northern blot analysis of cyclins gene expression in outer
mednllae of kidneys during regeneration period after ischemic injury.
Parallel blots with total RNA (20 j.g) from fetal (gestation day 19) kidney
(F), and from outer medullary tissue of control (C) period, and days 1, 3,
5, 7 and 14 after ischemic injury were examined. Fetal kidneys were used
as positive control. The radiolabeled cDNA probes used were: cyclin Dl
(Dl), cyclin D3 (D3), cyclin A (A), and cyclin B (B). Each blot was
rehybridized with a GAPDH probe to verify equal loading of RNA in each
lane. Results were similar from two or three separate experiments for each
cyclin. (B) Densitometric analysis of mRNA signals of cyclins in outer
medullae of kidneys during regeneration after ischemic injury. To present
relative mRNA level of each cyclin, densities of Northern blot signals were
used. Each cyclin level in fetal kidneys (F) was presented as 1. Data are
presented as mean values of relative ratios from two or three separate
experiments. Symbols are: (—LI--) cyclin Dl; (- 0') cyclin D3; (--0--) cyclin
A; (--ti--) cyclin B.
CDK2, cdc2 or PCNA in outer medullae at any time point of
sham-operated rats (data not shown).
Estimation of each CDK activity during active renal tubule
regeneration
To measure the functional activity of each CDK, we chose the
day 5 time point during active tubular regeneration, which had the
highest PT (based on PCNA immuno-positive staining) and high-
est levels of cyclin and CDK proteins. As a positive control, we
used protein lysates of fetal (gestation day 19) kidney, which has
a high proliferative activity. The specific antibodies for cyclin Dl
or cyclin A that were used for Western blot analysis were able to
bind either CDK4 or CDK2 in protein lysates of fetal kidneys and
outer medullae of adult kidneys, and were able to immunopre-
cipitate either CDK4 or CDK2 as immune complexes as con-
firmed by Western blotting (Figs. 5A and 6A). We compared the
co-immunoprecipitated protein levels with total protein levels of
CDK4 and CDK2 in fetal kidneys using densitometric analysis.
Approximately 24.6% (for CDK4) and 41.6% (for CDK2) of these
proteins were obtained by co-immunoprecipitation. Co-immuno-
precipitated CDK4 or CDK2 proteins were detected in fetal
kidneys and in the outer medullae of kidneys at day 5, while there
a .. —
a a
were no or barely detectable CDK4 or CDK2 proteins in the outer
medullae of kidneys at the control period or day 14 (Figs. 5A and
6A). To measure functional activities of these noticeable immu-
noprccipitated CDK4 or CDK2, GST-Rb protein or histone HI
was used as a substrate. The activities of CDK2 and CDK4 were
relatively high in fetal kidneys, while their levels were undetect-
able or low in the outer mcdullae of adult kidneys at the control
period (Figs. 5B, ÔB and 7). Three representative samples from
day 5 showed that CDK4 and CDK2 activities increased consis-
tently and significantly (Figs. 5B and 6B). Both levels returned to
basal levels at day 14. Interestingly, the increased levels of CDK4
activity at day 5 were 5 to 6 times greater than level of CDK4
activity of fetal kidneys, though the levels of co-immunoprecipi-
tated CDK4 protein at day 5 were much less than fetal kidneys.
Thus, another kinases co-immunoprecipitated with cyclin DI may
have been present and phosphorylated Rb in regenerating outer
medullae at day 5. The increased levels of CDK2 activities at day
5 were 1.3 to 1.7 times less than CDK2 activities of fetal kidneys
Fig. 3. .4. Western blot analysis of cyclins in outer medullae of kidneys
during the regeneration period after ischemic injury. Parallel blots with
total lysate protein (50 g) from fetal (gestation day 19) kidney (F), and
from the outer medullary tissue of control (C) period, and days 1, 3, 5, 7
and 14 after ischemic injury were examined. Fetal kidneys were used as
positive control. The antibodies used for each blot were described in the
Methods section. Results were similar from three separate experiments
for each cyclin. (B) Densitometric analysis of Western blot signals of
cyclins in outer medullae of kidneys during regeneration after ischemic
injury. To present the relative protein level of each cyclin, densities of
Western blot signals were used. Each cyclin level in fetal kidneys (F) was
presented as 1. Data are presented as mean values of relative ratios from
three separate experiments. Symbols are: (—s—) cyclin Dl, lower band;
(... O ...) cyclin Dl, upper band; (---0---) cyclin D3; (---tx---) cyclin A;(------) cyclin B.
(Figs. SB, 6B, and 7). The ratio of CDK2 activity between day 5
and fetal kidneys was approximately 2.5 if each densitometric
value of CDK2 activities was normalized by each densitometric
value of co-immunoprecipitated CDK2 protein level. The cdc2
activity at day 5 (111.4 8.9 cpm of 32P incorporated/j.tg of
protein/1() mill, N = 6) was significantly higher (7.2 2.4, N = 6)
than the control period, and was comparable level with that of
fetal kidneys (326.6 18.4, N = 6; Fig. 7). The cdc2 activity
returned to basal level by day 14.
DISCUSSION
The results of this study indicate that increased proliferative
activity of renal tubules for regeneration after ischemic renal
injury was associated with an up-regulation in the expression of
cyclins and CDKs and activation of CDKs in the outer medullae
of kidneys in rats. These changes revealed close temporal rela-
tionship with changes of proliferative activity in outer medullary
tubules. The levels of cyclins and CDKs, and the activation of
Park Ct at: Cyclin and CDK during regeneration after ARF 711
F C 1 3 5 7 10 14 (day)
A
B
Cyclin Dl
Cyclin D3
Cyclin A
Cyclin B
1.5
ci)0
II
0.5
0
F C 1 3 5 7 10 14
Day
a — — — —
a — — — — — — —
S I$
712 Park et al: Cyclin and CDK during regeneration after ARF
PCNA
CDK 4
CDK 2
A
F C 1 3 5 7 10 14 (day)
CDK4 )
A TF F C 5 14
cdc 2
1.25
1
0.5
0.25
0
B
GST-Rb )'
B
F C 5a 5b 5c 14
zoc
o- .2
Cl)
0.75
ccl
G)Oc
C1))
. .
ccl a
ci)
'I
T
F C 1 3 5 7 10 14
Day
Fig. 5. Induction of CDK4 activity in outer medullae of kidneys after
ischemic injury. (A) Western blot analysis of CDK4 after immunoprecipi-
tation with anti-cyclin Dl in 250 rg of total fetal kidney (F), outer
medullae of the control period (C), day 5, and day 14 after ischemic injury.
Fifty micrograms of total protein lysates (TF) from fetal kidney were used
as the positive and densitometric quantification control. (B) Autoradio-
graphic analysis of CDK4 activity in fetal kidneys (F), and in outer medulla
of control period (C), three samples from day 5 (5a, Sb, 5c), and one
sample from day 14 (14) after ischemic injury. GST-Rb protein was used
as the substrate. The detailed protocol was described in the Methods
section. Results were similar from two separate experiments.
phase of growth. More extensive renal ablation, such as 5/6
subtotal nephrectomy, causes a greater proliferative response in
the remaining viable renal tubule cells adjacent to the injured area
[12, 19]. However, neither cyclins nor CDKs were subject to a
significant induction in the remaining viable renal tissue after
subtotal nephrectomy, although there was an induction of c-fos
and PCNA. Thus, up-regulation and activation of cyclins/CDKs
was induced during the regenerative proliferative process after
acute ischemic injury, but was not induced during renal tubule
hypertrophy caused by unilateral nephrectomy and subtotal ne-
phrectomy.
Renal tubules in embryonic development exhibit abundant
proliferative capability, whereas renal tubules in adult mammals
exhibit no detectable or very low proliferative activity [20, 21].
From the standpoint of cell proliferation in vivo, the population of
cells can be divided into three groups in adults [22]. Some cells
divide continuously, going from mitosis through the Gi phase of
the cell cycle, the S (DNA synthesis) phase, the G2 phase, and
then to another mitosis. Bone marrow cells, intestinal epithelial
cells, and germ cells are examples of this type of cells. Another
type of cells leave the cell cycle after few divisions and differen-
tiate, never to divide again. Mature granulocytes, cardiomyocytes,
and neuronal cells are such terminally differentiated cells. Some
cells temporarily leave the cell cycle and remain reproductively
dormant (in the GO phase) although they still perform their
differentiated functions. These cells can be induced to re-enter the
cell cycle by appropriate environmental signal. This describes the
state of epithelial cells of renal tubules. The kidney is one of the
susceptible organs to injury by ischemia and nephrotoxin [1—3]. If
there is a minor or transient injury, the kidney has an ability to
Fig. 4. A. Western blot analysis of PCNA, CDK4, CDK2, and cdc2 in
outer medullae during regeneration period after ischemic injury. Parallel
blots with total lysate protein (50 .rg) from fetal (gestation day 19) kidney
(F), and from outer medullaiy tissue of control (C) period, day 1, 3, 5, 7
and 14 after ischemic injury were examined. Fetal kidneys were used as
positive control. The antibodies used for each blot were described in the
Methods section. Results were similar from three separate experiments
for PCNA and each CDK. (B) Densitometric analysis of Western blot
signals of CDK4, CDK2, cdc2 and PCNA in outer medullae of kidneys
during regeneration after ischemic injury. To present relative protein level
of each CDK or PCNA, densities of Western blot signals were used. Each
cyclin level in fetal kidneys (F) was presented as 1. Data are presented as
mean values of relative ratios from three separate experiments. Symbols
are: (—Eli—) CDK4; CDK2; (---0---) cdc2; (---A---) PCNA.
CDKS in the regenerating outer medullary tubules, were compa-
rable with those in highly proliferative fetal kidneys.
Recently, we have shown that compensatory hypertrophic renal
growth after unilateral nephrectomy did not increase any cyclins
or CDKs at any time point during the active phase of compensa-
tory hypertrophy [12]. In fact, PT was less than 3% in renal tubules
of compensatory hypertrophic renal growth during the active
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Fig. 6. Induction of CDK2 activity in outer medullae of kidneys after
ischemic injury. (4) Western blot analysis of CDK2 after immunoprecipi-
tation with anti-cyclin A in 250 g of total fetal kidney (F), outer medullae
of the control period (C), day 5 and day 14 after ischemic injury. Fifty
micrograms of total protein lysates (TF) from fetal kidney was used as
positive and densitometric quantification control. (B) Autoradiographic
analysis of CDK2 activity in fetal kidneys (F), and in outer medulla of
control period (C), three samples from day 5 (5a, 5b, Sc), and one sample
from day 14 (14) after ischemic injury. Histone Hi was used as the
substrate. The detailed protocol was described in the Methods section.
Results were similar from two separate experiments.
proliferate tubular epithelial cells and subsequently to recover
damaged epithelial lining of the tubules. However, massive loss of
renal tubules due to severe injury or disease during adulthood is
irreversible, and thereby, the potential therapeutic value for
tubule regeneration is quite substantial. Knowledge of the mech-
anisms that control the renal tubule cell cycle would allow us to
design procedures to initiate repair or regeneration of renal
tubules following injury. Unfortunately, the molecular and cellu-
lar mechanism of the mammalian renal tubule cell cycle during
the regeneration period after acute renal failure is not yet fully
understood.
The present study determined the active involvement of cell-
cycle regulatory proteins, the cyclin/CDK system, during regener-
ation of renal tubules after isehemie injury. Not only were the
expressions of cyclins and CDKs induced, but also CDK activities
increased during the active regeneration period. CDKs are a
family of serine/threonine kinases that are essential for cell cycle
progression [7, 10, 11]. Mammalian cells have evolved to use many
CDKs to regulate different stages of their cell cycles. D-type
cyclins are synthesized in the early Gi phase, and bind and
activate CDK4 as cells leave the quiescent phase [8, Generally,
up-regulation of growth factors and their receptors are known to
up-regulate the D-type cyclins (cyclin Dl, D2 and D3) and
increase binding availability to the Gi phase CDK (CDK4 and
CDK6) [8, 91. Accumulating evidence suggests that insulin-like
growth factor (IGF), heparin-binding epidermal growth factor-
like growth factor (HB-EGF), hepatocyte growth factor (HGF),
and their receptors are up-regulated during the regeneration
process of renal tubules after renal tubule injury [1, 4, 231.
Fig. 7. Densitometric analysis of CDK4 (12) and CDK2 (12) activities
and specific substrate assay of cdc2 (I) activity. To present relative
CDK4 and CDK2 activities, densities of autoradiographic signals were
used. Each CDK4 and CDK2 activity in fetal kidneys was presented as 1.
The cdc2 activity using substrate peptide (CSHIO3:H-A-D-A-Q-H-A-T-
P-P-K-K-K-R-K-V-E-D-P-K-D-F-OH) was assayed in 5 g of sample
protein. The detailed protocol was described in the Methods section. To
present the relative cdc2 activity, the radioactivity (32P incorporated
cpm/j.tg of protcin/lO mm) in fetal kidney was presented as 1. Results were
the mean values from six experiments. The legends of each period are the
same as shown in Figs. 5 and 6. Data are presented as mean standard
error of relative ratios from six experiments of each CDK activity.
Statistical analysis was performed using analysis as appropriate. Post-test
multiple comparisons were done by the method of Bonferroni. Signifi-
cance was accepted at the P < 0.05 level. *C versus 5; "C versus 14; #F
versus 5.
Moreover, administration of epidermal growth factor (EGF),
IGF, or HGF significantly accelerates renal regenerative activity
and capability [24 —261. Thus, these injury-inducible growth factors
and their receptors may facilitate renal regeneration by activating
the expression of cyclins Dl and D3, thereby increasing the
binding and activation of CDK4.
DNA synthesis occurs in S phase with activation of CDK2 [10,
11J. The protein levels and functional activities of CDK2 were
significantly increased during the regeneration period. Thus,
increased DNA synthesis in renal tubules after ischemic injury
may have been mediated by an increase of CDK2 activity. The
level of CDK2 activity was comparable with that of the highly
proliferative fetal kidney. The inimunohistochemical data of
PCNA were consistent with Western blot analysis of PCNA
during the regeneration period after isehemic injury. Our data
regarding temporal and spatial changes of PCNA during the
regeneration period after ischemic injury were consistent with
previous report [271. It is valuable to note that the induction of
PCNA was faster than the induction of cyclins and CDKs after
ischcmic renal injury. Interestingly, in vitro studies have suggested
an involvement of PCNA in DNA repair after DNA damage [28,
29j. The faster induction of PCNA at day 1 after isehemic injury
may be involved in DNA repair of damaged tubular cells. Then,
when the protein levels of PCNA were greatest at days 3 and 5
after ischemic injury, PCNA may have bound with the abundant
cyclins and CDKs to form complexes that participated in active
DNA synthesis in regenerating tubule cells. Based on PCNA
immuno-staining, proliferative activity was readily detectable in
renal tubules, interstitial cells and transitional epithelium of papil-
lae, but was hardly detectable in glomeruli and blood vessels. The
possible reason that glomeruli have very low proliferative activity is
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that glomeruli may contain a high level of pZ7, which is one of the
endogenous GI phase cyclin-dependent kinase inhibitors [30, 31].
Activity of cdc2 is necessary for G2IM phase transition of cell
cycle and mitosis in mammalian cells [10, 11]. In this study, cdc2
and cyclin B protein levels increased during the period of maxi-
mum regeneration after ischemic injury. Even though the protein
level of cdc2 increased slightly, the activity of cdc2 was signifi-
cantly higher at day 5 than at the control period, and was
comparable with that in the fetal kidney. This increased cdc2
protein in the outer medullae at day 5 after ischemic injury is
functionally active, and may be actively involved in the G2/M
phase of cell cycle transition and mitosis in renal tubules during
the period of maximum regeneration.
Finally, therapeutic interventions targeting to accelerate regen-
eration of renal tubules after ARF holds greater promise than the
classical conservative methods. The exogenous administration of
EGF, IGF-1 or HGF in the postischemic period has effectively
and reproducibly decreased the degree of renal insufficiency and
hastened renal recovery as measured by serum creatinine values,
and increased renal tubule DNA synthesis [24—261. It would be
valuable to compare the cyclin/CDK system in the presence and
absence of exogenous growth factor administration in the post-
ischemic period to evaluate the efficiency or elucidate the cellular
and molecular mechanisms of growth factor administration in the
future.
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